Currently, the share price for Akums Drugs & Pharmaceuticals Ltd. is delayed. Login to view live prices.
Akums Drugs & Pharmaceuticals Ltd.
₹625.65
NSE
-- ( -- %) 1D
Earnings Per Share
Earnings Per Share (EPS) is calculated by dividing a company’s net income by its average number of outstanding shares.
Income Statement
Also called a Profit & Loss statement, an Income Statement shows how a company has performed financially over a specific accounting period. It focuses on revenue, expenses, profits, and losses.
Particulars (In Cr) | Sep 2024 | Y/Y Change |
---|---|---|
Operating Revenue | 1,033.09 | +1.37% |
Other Income | 13.47 | +105.65% |
Total Income | 1,046.56 | +2.04% |
Total Expenditure | 911.90 | +2.33% |
EBIDT | 138.35 | +2.82% |
Depreciation | 34.86 | +2.35% |
Interest | 11.90 | -8.60% |
Tax | 24.94 | -5.06% |
Net Profit | 65.21 | +8.38% |
Balance Sheet
A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
Particulars (In Cr) | Mar 2024 | Y/Y Change |
---|---|---|
Total Current Assets | 1,940.88 | +0.87% |
Total Non-Current Assets | 1,575.48 | +17.37% |
Fixed assets | 1,384.12 | +15.50% |
Total assets | 3,516.36 | +7.65% |
Total Current Liabilities | 1,210.55 | -4.35% |
Total Non-Current Liabilities | 1,585.33 | +24.09% |
Total Capital Plus Liabilities | 3,516.36 | +7.65% |
Total Shareholder Funds | 709.50 | -1.07% |
Total Debt to Equity | 0.69 | -8.00% |
Cash Flow
The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
Particulars (In Cr) | Mar 2024 | Y/Y Change |
---|---|---|
Cash from Operating Activity | 498.26 | +182.09% |
Cash from Financing Activities | -108.02 | -186.74% |
Cash from Investing Activities | -330.42 | +8.44% |
Net Cash Flow | 59.82 | -1794.62% |
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer